Atlas Trials

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Clinical trial NCT05749822 · RECRUITING

Trial details

NCT number
NCT05749822
Sponsor
Xijing Hospital of Digestive Diseases
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Primary Biliary Cholangitis
Start date
2023-02-17
Primary completion
2027-12-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.